Robert Burns
Stock Analyst at HC Wainwright & Co.
(3.89)
# 702
Out of 5,182 analysts
522
Total ratings
44.33%
Success rate
11.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KPTI Karyopharm Therapeutics | Maintains: Buy | $8 → $13 | $9.41 | +38.15% | 6 | May 6, 2026 | |
| ADCT ADC Therapeutics | Reiterates: Buy | $8 | $3.76 | +112.77% | 24 | May 5, 2026 | |
| NUVB Nuvation Bio | Reiterates: Buy | $17 | $4.83 | +251.97% | 19 | May 5, 2026 | |
| FATE Fate Therapeutics | Maintains: Buy | $5 → $7 | $2.36 | +196.61% | 9 | May 4, 2026 | |
| RLAY Relay Therapeutics | Maintains: Buy | $19 → $25 | $13.00 | +92.31% | 24 | Apr 29, 2026 | |
| BDTX Black Diamond Therapeutics | Maintains: Buy | $10 → $11 | $2.87 | +283.28% | 15 | Apr 29, 2026 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $27 → $30 | $14.94 | +100.80% | 5 | Apr 28, 2026 | |
| PRLD Prelude Therapeutics | Maintains: Buy | $5 → $8 | $4.67 | +71.31% | 18 | Apr 27, 2026 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $32 | $16.60 | +92.77% | 24 | Apr 27, 2026 | |
| BNTX BioNTech SE | Reiterates: Buy | $130 | $95.50 | +36.13% | 48 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $169 | $147.21 | +14.80% | 23 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.25 | +205.88% | 4 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $2.17 | +406.91% | 19 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $11.04 | +81.16% | 6 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $2.87 | - | 21 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.93 | +366.32% | 16 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $9.57 | +161.23% | 29 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $19.44 | +69.75% | 2 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $42 | $23.16 | +81.35% | 6 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $9.56 | +56.90% | 12 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $56 | $41.58 | +34.68% | 6 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $27 | $8.51 | +217.27% | 4 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $13 | $3.65 | +256.16% | 7 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $27 | $4.52 | +497.35% | 5 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $17 | $10.59 | +60.53% | 9 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.66 | +50.21% | 2 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $44 | $29.83 | +47.50% | 12 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $29 | $8.27 | +250.67% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $27 | $24.20 | +11.57% | 13 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $46 | $26.68 | +72.41% | 24 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $54 | $44.42 | +21.57% | 15 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.32 | +331.03% | 5 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.61 | +521.12% | 4 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $52 | $36.98 | +40.62% | 16 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $2 | $3.15 | -36.51% | 22 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.37 | +264.96% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.76 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $16.00 | +1,150.00% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $0.21 | +113,107.55% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.38 | +39,363.30% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $4.08 | +169.61% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $2.19 | +2,054,694.52% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.64 | +692.68% | 1 | Jan 7, 2021 |
Karyopharm Therapeutics
May 6, 2026
Maintains: Buy
Price Target: $8 → $13
Current: $9.41
Upside: +38.15%
ADC Therapeutics
May 5, 2026
Reiterates: Buy
Price Target: $8
Current: $3.76
Upside: +112.77%
Nuvation Bio
May 5, 2026
Reiterates: Buy
Price Target: $17
Current: $4.83
Upside: +251.97%
Fate Therapeutics
May 4, 2026
Maintains: Buy
Price Target: $5 → $7
Current: $2.36
Upside: +196.61%
Relay Therapeutics
Apr 29, 2026
Maintains: Buy
Price Target: $19 → $25
Current: $13.00
Upside: +92.31%
Black Diamond Therapeutics
Apr 29, 2026
Maintains: Buy
Price Target: $10 → $11
Current: $2.87
Upside: +283.28%
Cullinan Therapeutics
Apr 28, 2026
Maintains: Buy
Price Target: $27 → $30
Current: $14.94
Upside: +100.80%
Prelude Therapeutics
Apr 27, 2026
Maintains: Buy
Price Target: $5 → $8
Current: $4.67
Upside: +71.31%
Nurix Therapeutics
Apr 27, 2026
Reiterates: Buy
Price Target: $32
Current: $16.60
Upside: +92.77%
BioNTech SE
Apr 27, 2026
Reiterates: Buy
Price Target: $130
Current: $95.50
Upside: +36.13%
Apr 22, 2026
Reiterates: Buy
Price Target: $169
Current: $147.21
Upside: +14.80%
Apr 22, 2026
Reiterates: Buy
Price Target: $13
Current: $4.25
Upside: +205.88%
Apr 16, 2026
Maintains: Buy
Price Target: $12 → $11
Current: $2.17
Upside: +406.91%
Apr 13, 2026
Reiterates: Buy
Price Target: $20
Current: $11.04
Upside: +81.16%
Apr 13, 2026
Downgrades: Sell
Price Target: n/a
Current: $2.87
Upside: -
Apr 7, 2026
Reiterates: Buy
Price Target: $9
Current: $1.93
Upside: +366.32%
Apr 2, 2026
Reiterates: Buy
Price Target: $25
Current: $9.57
Upside: +161.23%
Mar 31, 2026
Maintains: Buy
Price Target: $30 → $33
Current: $19.44
Upside: +69.75%
Mar 31, 2026
Maintains: Buy
Price Target: $40 → $42
Current: $23.16
Upside: +81.35%
Mar 30, 2026
Reiterates: Buy
Price Target: $15
Current: $9.56
Upside: +56.90%
Mar 26, 2026
Maintains: Buy
Price Target: $48 → $56
Current: $41.58
Upside: +34.68%
Mar 23, 2026
Maintains: Buy
Price Target: $50 → $27
Current: $8.51
Upside: +217.27%
Mar 23, 2026
Maintains: Buy
Price Target: $12 → $13
Current: $3.65
Upside: +256.16%
Mar 16, 2026
Maintains: Buy
Price Target: $34 → $27
Current: $4.52
Upside: +497.35%
Mar 13, 2026
Maintains: Buy
Price Target: $13 → $17
Current: $10.59
Upside: +60.53%
Mar 13, 2026
Reiterates: Buy
Price Target: $7
Current: $4.66
Upside: +50.21%
Mar 6, 2026
Maintains: Buy
Price Target: $42 → $44
Current: $29.83
Upside: +47.50%
Mar 6, 2026
Maintains: Buy
Price Target: $27 → $29
Current: $8.27
Upside: +250.67%
Mar 6, 2026
Maintains: Buy
Price Target: $13 → $27
Current: $24.20
Upside: +11.57%
Mar 6, 2026
Maintains: Buy
Price Target: $32 → $46
Current: $26.68
Upside: +72.41%
Feb 12, 2026
Maintains: Buy
Price Target: $52 → $54
Current: $44.42
Upside: +21.57%
Feb 3, 2026
Reiterates: Buy
Price Target: $10
Current: $2.32
Upside: +331.03%
Jan 28, 2026
Reiterates: Buy
Price Target: $10
Current: $1.61
Upside: +521.12%
Jan 6, 2026
Maintains: Buy
Price Target: $50 → $52
Current: $36.98
Upside: +40.62%
Nov 3, 2025
Reiterates: Neutral
Price Target: $2
Current: $3.15
Upside: -36.51%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.37
Upside: +264.96%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.76
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $16.00
Upside: +1,150.00%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $0.21
Upside: +113,107.55%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.38
Upside: +39,363.30%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $4.08
Upside: +169.61%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $2.19
Upside: +2,054,694.52%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.64
Upside: +692.68%